title: Insulysin cleaves the APP cytoplasmic fragment at multiple sites.
abstract: The amyloid peptide (Abeta) deposited in Alzheimer's disease (AD) is generated by beta- and gamma-secretase processing of a larger integral membrane protein precursor (APP). Intramembrane processing of APP by gamma-secretase also yields an intracellular fragment, CTFgamma (a.k.a. AICD), which is highly conserved and is believed to regulate the transcription of several genes including KAI-1 and GSK3beta. The intracellular domain of APP is also processed by caspase to a 31 aa fragment that was shown to induce apoptosis by several groups. Although large quantities of CTFgamma are generated continuously by neurons, little if any is normally detected in cell lysates, which suggests that it is very rapidly turned over in vivo. Previous studies demonstrated that insulysin (IDE), an Abeta-degrading enzyme, is responsible for cytosol-mediated CTFgamma degradation in vitro. Consistent with this finding, knockout mice lacking IDE accumulate CTFgamma to detectable levels in the brain, although its levels remain lower than its precursor, suggesting that it continues to be turned over in the brain. Moreover, when we treated cultured cells with IDE inhibitors, we did not observe an increase in CTFgamma in cell lysates, suggesting that pathways other than IDE are also involved in CTFgamma turnover. To understand CTFgamma turnover further, we have mapped the IDE cleavage sites with the intention of mutating them to examine alternative pathways in future studies. Edman degradation revealed that IDE cleaves CTFgamma at multiple sites to small peptides ranging from 5 to 14 aa. The cleavage sites do not reveal the existence of any sequence specificity for IDE cleavage. Understanding the turnover mechanisms of CTFgamma is critical to the understanding of the signaling function of APP mediated by this fragment. The current study presents the interesting specificity of CTFgamma turnover by IDE, which has been previously identified as the major degrading enzyme for Abeta as well as CTFgamma. In addition, the study provides evidence for the presence of alternative CTFgamma-degrading pathways in the cell.
authors: Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
authors: Chitra
authors: C
authors: Venugopal
authors: Miguel A
authors: MA
authors: Pappolla
authors: Kumar
authors: K
authors: Sambamurti
mesh_terms: D000595:Amino Acid Sequence; D016564:Amyloid beta-Protein Precursor / Q000737:chemistry*; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D003593:Cytoplasm / Q000737:chemistry*; D005260:Female; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007339:Insulysin / Q000737:chemistry*; D051379:Mice; D008969:Molecular Sequence Data; D011480:Protease Inhibitors / Q000494:pharmacology; D016622:Silver Staining; D013379:Substrate Specificity
chemical_list: D016564:Amyloid beta-Protein Precursor; D005452:Fluoresceins; D005456:Fluorescent Dyes; D011480:Protease Inhibitors; D007339:Insulysin
references: Cell. 1993 Dec 17;75(6):1039-42
references: 8261505
references: J Biol Chem. 2001 Sep 21;276(38):35235-8
references: 11483588
references: Nature. 2001 Dec 6;414(6864):643-8
references: 11740561
references: J Cell Sci. 2002 Apr 1;115(Pt 7):1411-22
references: 11896189
references: J Biol Chem. 2004 Jun 4;279(23 ):24601-11
references: 15044485
references: J Alzheimers Dis. 2000 Nov;2(3-4):289-301
references: 12214090
references: Nature. 1993 Jan 21;361(6409):260-3
references: 7678698
references: Ann N Y Acad Sci. 1992 Dec 31;674:118-28
references: 1283818
references: FEBS Lett. 1992 Dec 21;314(3):315-21
references: 1334849
references: Mol Cell Biol. 1996 Nov;16(11):6229-41
references: 8887653
references: J Biol Chem. 1995 Dec 29;270(52):30853-6
references: 8537337
references: Curr Drug Targets. 2004 Aug;5(6):517-28
references: 15270198
references: J Biol Chem. 2006 May 26;281(21):14776-86
references: 16595682
references: J Neurosci. 2003 Jul 2;23(13):5407-15
references: 12843239
references: J Biol Chem. 2001 Nov 23;276(47):43756-60
references: 11583985
references: J Alzheimers Dis. 2006;9(3 Suppl):341-7
references: 16914872
references: J Biol Chem. 2002 Nov 15;277(46):44195-201
references: 12228233
references: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7
references: 12634421
references: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14745-50
references: 9843960
references: FEBS Lett. 1996 Nov 18;397(2-3):197-200
references: 8955346
references: J Biol Chem. 1998 Oct 23;273(43):27765-7
references: 9774383
references: Science. 2001 Jul 6;293(5527):115-20
references: 11441186
references: J Neurochem. 2006 Feb;96(3):732-42
references: 16405513
references: J Pharmacol Sci. 2005 Apr;97(4):461-71
references: 15821343
references: Neuron. 2003 Dec 18;40(6):1087-93
references: 14687544
references: Science. 1990 Jun 1;248(4959):1122-4
references: 2111583
references: J Neurosci. 2001 Sep 1;21(17):6597-607
references: 11517249
references: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6221-6
references: 12732730
references: FEBS Lett. 1998 May 8;427(2):153-6
references: 9607302
references: Cell. 1999 Apr 30;97(3):395-406
references: 10319819
references: FASEB J. 2003 Oct;17 (13):1951-3
references: 12923068
references: Neurobiol Dis. 2004 Nov;17(2):205-18
references: 15474359
references: J Biol Chem. 2001 Oct 26;276(43):40288-92
references: 11544248
references: Neuron. 2002 Jan 31;33(3):321-4
references: 11832221
references: J Neurochem. 2001 Sep;78(5):1168-78
references: 11553691
references: Nat Med. 2000 Apr;6(4):397-404
references: 10742146
references: Physiol Rev. 2001 Apr;81(2):741-66
references: 11274343
references: J Biol Chem. 2001 Jan 5;276(1):481-7
references: 11035007
references: Cell. 2002 Jul 12;110(1):55-67
references: 12150997
references: Nature. 2006 Oct 19;443(7113):870-4
references: 17051221
references: EMBO Rep. 2001 Sep;2(9):835-41
references: 11520861
references: J Biol Chem. 1999 Aug 13;274(33):23426-36
references: 10438520
references: Cell. 2006 Oct 20;127(2):305-16
references: 17055432
references: J Biol Chem. 1999 Mar 19;274(12):7952-7
references: 10075692
references: Neuromolecular Med. 2002;1(1):1-31
references: 12025813
references: Curr Psychiatry Rep. 2004 Apr;6(2):125-33
references: 15038915
references: J Neurochem. 1999 Sep;73(3):985-93
references: 10461887
references: Exp Neurol. 2004 Feb;185(2):208-19
references: 14736502
references: Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3922-7
references: 10097139
references: Biochem J. 1999 Oct 15;343 Pt 2:371-5
references: 10510302
references: J Biol Chem. 2006 Nov 17;281(46):35176-85
references: 16951405
references: J Cell Biol. 2003 Oct 13;163(1):27-33
references: 14557245
references: J Biol Chem. 2007 Feb 16;282(7):4318-25
references: 17170108
references: J Cell Biol. 2005 Oct 24;171(2):327-35
references: 16230462
references: J Biol Chem. 2002 Apr 19;277(16):13389-93
references: 11809755
references: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4697-702
references: 11917117
references: Biochemistry. 2002 Feb 26;41(8):2825-35
references: 11851430
references: J Neurochem. 2005 May;93(4):769-92
references: 15857382